nodes	percent_of_prediction	percent_of_DWPC	metapath
Vapreotide—SSTR2—Signaling by GPCR—PIK3CG—melanoma	0.000361	0.000361	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—MAP2K2—melanoma	0.000355	0.000355	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—SYK—melanoma	0.000353	0.000353	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—PIK3CD—melanoma	0.00035	0.00035	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—SOCS1—melanoma	0.000347	0.000347	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—F2R—melanoma	0.000347	0.000347	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—MAP2K1—melanoma	0.000346	0.000346	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—S100B—melanoma	0.000346	0.000346	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—ITGAV—melanoma	0.000346	0.000346	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—AKT3—melanoma	0.000346	0.000346	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NGFR—melanoma	0.000346	0.000346	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—PIK3CD—melanoma	0.000344	0.000344	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—RAC1—melanoma	0.000337	0.000337	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—EDNRB—melanoma	0.000336	0.000336	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—ERBB4—melanoma	0.000331	0.000331	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—PIK3CB—melanoma	0.00033	0.00033	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CDKN2B—melanoma	0.000328	0.000328	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PTK2B—melanoma	0.000326	0.000326	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—SOCS1—melanoma	0.00032	0.00032	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—MAP2K1—melanoma	0.00032	0.00032	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—S100B—melanoma	0.00032	0.00032	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—PIK3CD—melanoma	0.000318	0.000318	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CD86—melanoma	0.000318	0.000318	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—GAB2—melanoma	0.000318	0.000318	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—GNA11—melanoma	0.000318	0.000318	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—CXCL8—melanoma	0.000317	0.000317	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—FLT1—melanoma	0.000316	0.000316	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—EDN1—melanoma	0.000315	0.000315	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—PIK3CG—melanoma	0.000313	0.000313	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—FGF1—melanoma	0.000308	0.000308	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CSF2—melanoma	0.000308	0.000308	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—ERBB4—melanoma	0.000306	0.000306	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—PIK3CB—melanoma	0.000305	0.000305	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—IL2—melanoma	0.000303	0.000303	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CDKN2B—melanoma	0.000303	0.000303	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—E2F1—melanoma	0.000301	0.000301	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—PIK3CB—melanoma	0.0003	0.0003	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—FOXO4—melanoma	0.000299	0.000299	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—HDAC2—melanoma	0.000299	0.000299	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CXCR4—melanoma	0.000299	0.000299	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PDGFRA—melanoma	0.000298	0.000298	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PRKCA—melanoma	0.000295	0.000295	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—GNAQ—melanoma	0.000295	0.000295	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—ITGB3—melanoma	0.000295	0.000295	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CD86—melanoma	0.000293	0.000293	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CXCL8—melanoma	0.000293	0.000293	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—EDN1—melanoma	0.000291	0.000291	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—SPP1—melanoma	0.00029	0.00029	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MAP2K2—melanoma	0.000289	0.000289	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CXCL8—melanoma	0.000288	0.000288	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PIK3CG—melanoma	0.000284	0.000284	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CSF2—melanoma	0.000284	0.000284	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—FGF1—melanoma	0.000284	0.000284	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—IL2—melanoma	0.00028	0.00028	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—E2F1—melanoma	0.000278	0.000278	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—SYK—melanoma	0.000278	0.000278	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—PIK3CB—melanoma	0.000277	0.000277	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—IL2—melanoma	0.000275	0.000275	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—PIK3CD—melanoma	0.000275	0.000275	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PDGFRA—melanoma	0.000275	0.000275	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TERT—melanoma	0.000274	0.000274	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—RAC1—melanoma	0.000274	0.000274	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—ITGB3—melanoma	0.000272	0.000272	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—ITGAV—melanoma	0.000272	0.000272	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—AKT3—melanoma	0.000272	0.000272	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PRKCA—melanoma	0.000272	0.000272	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NGFR—melanoma	0.000272	0.000272	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—SPP1—melanoma	0.000267	0.000267	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MAP2K2—melanoma	0.000266	0.000266	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CXCL8—melanoma	0.000266	0.000266	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—HIF1A—melanoma	0.000263	0.000263	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—IL2—melanoma	0.000254	0.000254	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TERT—melanoma	0.000253	0.000253	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—RAC1—melanoma	0.000253	0.000253	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—SOCS1—melanoma	0.000252	0.000252	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—MAP2K1—melanoma	0.000252	0.000252	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—S100B—melanoma	0.000252	0.000252	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—KDR—melanoma	0.000251	0.000251	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PIK3CD—melanoma	0.00025	0.00025	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—HIF1A—melanoma	0.000242	0.000242	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—FN1—melanoma	0.000242	0.000242	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—ERBB4—melanoma	0.000241	0.000241	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—PIK3CB—melanoma	0.00024	0.00024	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CDKN2B—melanoma	0.000239	0.000239	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—NOTCH1—melanoma	0.000236	0.000236	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—KDR—melanoma	0.000232	0.000232	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CD80—melanoma	0.000232	0.000232	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—KIT—melanoma	0.000231	0.000231	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—APC—melanoma	0.000231	0.000231	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PIK3CG—melanoma	0.000231	0.000231	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—NRAS—melanoma	0.000231	0.000231	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CD86—melanoma	0.000231	0.000231	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CXCL8—melanoma	0.000231	0.000231	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—EDN1—melanoma	0.000229	0.000229	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—EGF—melanoma	0.000229	0.000229	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CSF2—melanoma	0.000224	0.000224	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—FGF1—melanoma	0.000224	0.000224	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—FN1—melanoma	0.000223	0.000223	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—MAPK3—melanoma	0.000221	0.000221	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—IL2—melanoma	0.00022	0.00022	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—E2F1—melanoma	0.000219	0.000219	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NOTCH1—melanoma	0.000218	0.000218	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PIK3CB—melanoma	0.000218	0.000218	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—BRAF—melanoma	0.000217	0.000217	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PDGFRA—melanoma	0.000217	0.000217	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PRKCA—melanoma	0.000215	0.000215	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—ITGB3—melanoma	0.000215	0.000215	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CD80—melanoma	0.000214	0.000214	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PIK3CG—melanoma	0.000213	0.000213	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—APC—melanoma	0.000213	0.000213	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—KIT—melanoma	0.000213	0.000213	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—NRAS—melanoma	0.000213	0.000213	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IGF1—melanoma	0.000212	0.000212	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—EGF—melanoma	0.000211	0.000211	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—MAPK1—melanoma	0.000211	0.000211	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—EGFR—melanoma	0.000211	0.000211	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—SPP1—melanoma	0.00021	0.00021	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MAP2K2—melanoma	0.00021	0.00021	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CXCL8—melanoma	0.000209	0.000209	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MAP2K1—melanoma	0.000205	0.000205	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—MAPK3—melanoma	0.000204	0.000204	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PIK3CD—melanoma	0.000203	0.000203	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—PIK3CA—melanoma	0.000201	0.000201	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—BRAF—melanoma	0.000201	0.000201	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—IL2—melanoma	0.0002	0.0002	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TERT—melanoma	0.000199	0.000199	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—KRAS—melanoma	0.000199	0.000199	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—RAC1—melanoma	0.000199	0.000199	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IGF1—melanoma	0.000195	0.000195	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—FGF2—melanoma	0.000195	0.000195	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—MAPK1—melanoma	0.000194	0.000194	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—EGFR—melanoma	0.000194	0.000194	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—HIF1A—melanoma	0.000191	0.000191	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MAP2K1—melanoma	0.000189	0.000189	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PIK3CD—melanoma	0.000188	0.000188	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—PIK3CA—melanoma	0.000186	0.000186	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—KRAS—melanoma	0.000184	0.000184	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—PIK3CA—melanoma	0.000183	0.000183	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—KDR—melanoma	0.000182	0.000182	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MDM2—melanoma	0.000182	0.000182	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—FGF2—melanoma	0.00018	0.00018	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—ERBB2—melanoma	0.00018	0.00018	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PIK3CB—melanoma	0.000177	0.000177	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—FN1—melanoma	0.000176	0.000176	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NOTCH1—melanoma	0.000172	0.000172	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CXCL8—melanoma	0.00017	0.00017	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—HRAS—melanoma	0.000169	0.000169	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—PIK3CA—melanoma	0.000169	0.000169	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CD80—melanoma	0.000168	0.000168	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MDM2—melanoma	0.000168	0.000168	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PIK3CG—melanoma	0.000168	0.000168	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—APC—melanoma	0.000168	0.000168	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—KIT—melanoma	0.000168	0.000168	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—NRAS—melanoma	0.000168	0.000168	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CDKN1B—melanoma	0.000166	0.000166	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—EGF—melanoma	0.000166	0.000166	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—ERBB2—melanoma	0.000166	0.000166	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—AKT1—melanoma	0.000165	0.000165	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PIK3CB—melanoma	0.000164	0.000164	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CASP3—melanoma	0.000163	0.000163	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IL2—melanoma	0.000163	0.000163	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—IL6—melanoma	0.000162	0.000162	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—MAPK3—melanoma	0.000161	0.000161	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CCND1—melanoma	0.000159	0.000159	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—BRAF—melanoma	0.000158	0.000158	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CXCL8—melanoma	0.000157	0.000157	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CTNNB1—melanoma	0.000157	0.000157	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—HRAS—melanoma	0.000156	0.000156	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MMP9—melanoma	0.000154	0.000154	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IGF1—melanoma	0.000154	0.000154	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CDKN1B—melanoma	0.000153	0.000153	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CDKN1A—melanoma	0.000153	0.000153	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PTEN—melanoma	0.000153	0.000153	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—MAPK1—melanoma	0.000153	0.000153	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—EGFR—melanoma	0.000153	0.000153	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—NFKB1—melanoma	0.000152	0.000152	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—AKT1—melanoma	0.000152	0.000152	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CASP3—melanoma	0.00015	0.00015	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IL2—melanoma	0.00015	0.00015	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—IL6—melanoma	0.000149	0.000149	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—AKT1—melanoma	0.000149	0.000149	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MAP2K1—melanoma	0.000149	0.000149	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PIK3CD—melanoma	0.000148	0.000148	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCND1—melanoma	0.000146	0.000146	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—PIK3CA—melanoma	0.000146	0.000146	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CTNNB1—melanoma	0.000145	0.000145	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—KRAS—melanoma	0.000145	0.000145	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MMP9—melanoma	0.000142	0.000142	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CDKN1A—melanoma	0.000142	0.000142	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—FGF2—melanoma	0.000141	0.000141	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PTEN—melanoma	0.000141	0.000141	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NFKB1—melanoma	0.000141	0.000141	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—VEGFA—melanoma	0.000138	0.000138	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—AKT1—melanoma	0.000138	0.000138	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—STAT3—melanoma	0.000137	0.000137	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—NRAS—melanoma	0.000137	0.000137	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PIK3CA—melanoma	0.000133	0.000133	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MDM2—melanoma	0.000132	0.000132	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MAPK3—melanoma	0.000131	0.000131	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—ERBB2—melanoma	0.00013	0.00013	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PIK3CB—melanoma	0.000129	0.000129	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—VEGFA—melanoma	0.000128	0.000128	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MYC—melanoma	0.000127	0.000127	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—STAT3—melanoma	0.000126	0.000126	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NRAS—melanoma	0.000126	0.000126	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MAPK1—melanoma	0.000124	0.000124	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—EGFR—melanoma	0.000124	0.000124	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CXCL8—melanoma	0.000124	0.000124	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—HRAS—melanoma	0.000123	0.000123	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CDKN1B—melanoma	0.000121	0.000121	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MAPK3—melanoma	0.000121	0.000121	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—AKT1—melanoma	0.00012	0.00012	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CASP3—melanoma	0.000118	0.000118	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IL2—melanoma	0.000118	0.000118	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—IL6—melanoma	0.000118	0.000118	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—KRAS—melanoma	0.000118	0.000118	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MYC—melanoma	0.000117	0.000117	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCND1—melanoma	0.000115	0.000115	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MAPK1—melanoma	0.000115	0.000115	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—EGFR—melanoma	0.000115	0.000115	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CTNNB1—melanoma	0.000114	0.000114	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MMP9—melanoma	0.000112	0.000112	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CDKN1A—melanoma	0.000112	0.000112	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PTEN—melanoma	0.000111	0.000111	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NFKB1—melanoma	0.000111	0.000111	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—AKT1—melanoma	0.000109	0.000109	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—KRAS—melanoma	0.000109	0.000109	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PIK3CA—melanoma	0.000108	0.000108	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TP53—melanoma	0.000105	0.000105	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—VEGFA—melanoma	0.0001	0.0001	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—HRAS—melanoma	9.99e-05	9.99e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PIK3CA—melanoma	9.97e-05	9.97e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—STAT3—melanoma	9.95e-05	9.95e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NRAS—melanoma	9.93e-05	9.93e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TP53—melanoma	9.64e-05	9.64e-05	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IL6—melanoma	9.57e-05	9.57e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MAPK3—melanoma	9.51e-05	9.51e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MYC—melanoma	9.25e-05	9.25e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—HRAS—melanoma	9.22e-05	9.22e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MAPK1—melanoma	9.05e-05	9.05e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—EGFR—melanoma	9.04e-05	9.04e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IL6—melanoma	8.83e-05	8.83e-05	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—AKT1—melanoma	8.82e-05	8.82e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—KRAS—melanoma	8.54e-05	8.54e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—AKT1—melanoma	8.14e-05	8.14e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PIK3CA—melanoma	7.85e-05	7.85e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TP53—melanoma	7.59e-05	7.59e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—HRAS—melanoma	7.26e-05	7.26e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IL6—melanoma	6.95e-05	6.95e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—AKT1—melanoma	6.41e-05	6.41e-05	CbGpPWpGaD
